ATE202472T1 - Arzneimittel enthaltend oxaliplatin - Google Patents

Arzneimittel enthaltend oxaliplatin

Info

Publication number
ATE202472T1
ATE202472T1 AT99301412T AT99301412T ATE202472T1 AT E202472 T1 ATE202472 T1 AT E202472T1 AT 99301412 T AT99301412 T AT 99301412T AT 99301412 T AT99301412 T AT 99301412T AT E202472 T1 ATE202472 T1 AT E202472T1
Authority
AT
Austria
Prior art keywords
products containing
medicinal products
containing oxaliplatin
oxaliplatin
medicinal
Prior art date
Application number
AT99301412T
Other languages
English (en)
Inventor
Nicholas H Anderson
Ross Blundell
Stephen Brown
David A England
Martin R Gray
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10827600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE202472(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE202472T1 publication Critical patent/ATE202472T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT99301412T 1998-02-25 1999-02-25 Arzneimittel enthaltend oxaliplatin ATE202472T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9804013.2A GB9804013D0 (en) 1998-02-25 1998-02-25 Formulations

Publications (1)

Publication Number Publication Date
ATE202472T1 true ATE202472T1 (de) 2001-07-15

Family

ID=10827600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99301412T ATE202472T1 (de) 1998-02-25 1999-02-25 Arzneimittel enthaltend oxaliplatin

Country Status (27)

Country Link
US (1) US6306902B1 (de)
EP (1) EP0943331B1 (de)
JP (1) JP4430229B2 (de)
KR (1) KR20010041182A (de)
CN (1) CN1152718C (de)
AR (1) AR015524A1 (de)
AT (1) ATE202472T1 (de)
AU (1) AU757101B2 (de)
BR (1) BR9908273A (de)
CA (1) CA2261500C (de)
CZ (1) CZ302196B6 (de)
DE (1) DE69900162T2 (de)
DK (1) DK0943331T3 (de)
ES (1) ES2161085T3 (de)
GB (1) GB9804013D0 (de)
GR (1) GR3036646T3 (de)
GT (1) GT199900019A (de)
HU (1) HU224611B1 (de)
IL (1) IL137772A (de)
MX (1) MXPA00008195A (de)
NO (1) NO329900B1 (de)
PL (1) PL197948B1 (de)
PT (1) PT943331E (de)
RU (1) RU2207857C2 (de)
UA (1) UA70316C2 (de)
WO (1) WO1999043355A2 (de)
ZA (1) ZA991489B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
BRPI9914508B8 (pt) * 1998-10-14 2021-05-25 Debiopharm Sa bolsa flexível impermeável para uso médico contendo uma preparação farmacêutica de oxaliplatina sob a forma líquida
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
JP4890711B2 (ja) * 1999-08-30 2012-03-07 デビオファーム ソシエテ アノニム 非経口投与のための医薬として安定なオキザリプラチナム製剤
EP1341555A2 (de) * 2000-12-12 2003-09-10 Debiopharm S.A. Oxaliplatinhaltige parenteral anzuwendende arzneizubereitung und verfahren zu deren herstellung
US20040220078A1 (en) 2001-03-02 2004-11-04 Houssam Ibrahim Device for packaging an oxaliplatinum solution
US20040186172A1 (en) 2001-07-02 2004-09-23 Houssam Ibrahim Oxaliplatin active substance with a very low content of oxalic acid
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
CA2388352A1 (en) * 2002-05-31 2003-11-30 Voiceage Corporation A method and device for frequency-selective pitch enhancement of synthesized speed
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
US20050020556A1 (en) * 2003-05-30 2005-01-27 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
GB2441445B (en) * 2003-08-28 2008-04-23 Mayne Pharma Ltd Acid containing oxaliplatin formulation
WO2005020980A1 (en) * 2003-08-28 2005-03-10 Mayne Pharma Pty Ltd Acid containing oxaliplatin formulations
JP2007504177A (ja) * 2003-09-02 2007-03-01 プリヴァ−ラケマ，エー．エス． 医薬組成物、その製造方法及び治療上の使用
CZ300795B6 (cs) * 2003-09-02 2009-08-12 Pliva-Lachema A. S. Farmaceutická kompozice a zpusob její výroby
US7576126B2 (en) 2003-11-25 2009-08-18 Platco Technologies (Proprietary) Limited Platinum (II) complexes, preparation and use
PL1695991T3 (pl) * 2003-12-10 2010-05-31 Toudai Tlo Ltd Koordynacyjny kompleks diaminocykloheksanu platyny (II) z blokowym kopolimerem zawierającym fragment poli(kwasu karboksylowego), oraz środek przeciw-nowotworowy zawierający ten kompleks
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
WO2005102312A1 (en) * 2004-04-27 2005-11-03 Mayne Pharma Limited Concentrated oxaliplatin solutions
EP2011798B1 (de) 2004-09-01 2011-06-29 Platco Technologies (Proprietary) Limited Herstellung von Platin (II)-Komplexen
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
EP1879568B1 (de) * 2005-03-28 2009-05-06 Dabur Pharma Limited Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
WO2006108428A1 (en) * 2005-04-09 2006-10-19 Vuab Pharma A.S. A process for the preparation of an oxaliplatin preparation
RU2292210C1 (ru) * 2005-05-03 2007-01-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения стерилизованной микрокристаллической цис-дихлородиамминплатины (ii)
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (en) * 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
RU2008135369A (ru) 2006-01-30 2010-03-10 Платко Текнолоджис (Проприэтэри) Лимитед (Za) Получение комплексов платины(ii)
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
JP2010516717A (ja) * 2007-01-22 2010-05-20 プリヴァ−ラケマ，エー．エス． アルコール性糖ベースのバッファーを有するオキサリプラチン薬学的組成物
RU2340347C2 (ru) * 2007-01-24 2008-12-10 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения стерилизованной микрокристаллической соли цис-дихлороамминизопропиламинплатины (ii)
WO2009087660A1 (en) * 2007-11-12 2009-07-16 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
WO2010056847A2 (en) * 2008-11-13 2010-05-20 Taigen Biotechnology Co., Ltd. Lyophilization formulation
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
KR101396461B1 (ko) 2009-09-21 2014-05-20 (주)바이오시네틱스 옥살리플라틴의 나노 입자 및 이를 제조하는 방법
CN102274171A (zh) * 2011-08-04 2011-12-14 上海希迪制药有限公司 一种奥沙利铂注射剂
CN104523674B (zh) * 2014-12-11 2017-10-24 广州市上为医药科技有限公司 一种以奥沙利铂为主药成分的注射用组合物
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CN104829653B (zh) * 2015-05-06 2016-03-23 山东罗欣药业集团股份有限公司 一种奥沙利铂水合物晶体及其冻干粉针剂
AU2019206492B2 (en) 2018-01-12 2025-01-09 Metimedi Pharmaceuticals Co., Ltd. Methods of treating chronic inflammatory diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
PT93772A (pt) 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
WO1991009042A1 (fr) 1989-12-15 1991-06-27 Tsumura & Co. Nouveau complexe de platine et medicament antitumoral le contenant comme ingredient actif
JPH04185601A (ja) * 1990-11-20 1992-07-02 Unitika Ltd 白金抗癌剤徐放性製剤
CA2123321C (en) * 1991-11-15 2003-09-30 Randall Keith Johnson Combination chemotherapy
JPH0776230B2 (ja) * 1992-01-13 1995-08-16 田中貴金属工業株式会社 白金化合物の製造方法
JPH05238936A (ja) 1992-02-27 1993-09-17 Dainippon Pharmaceut Co Ltd カルシトリオールの水性液剤
JPH06287021A (ja) * 1992-04-22 1994-10-11 Tanaka Kikinzoku Kogyo Kk 光学活性な白金錯化合物の光学的分割方法
JP2673331B2 (ja) * 1993-01-12 1997-11-05 田中貴金属工業 株式会社 光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
AU5416394A (en) * 1992-11-24 1994-06-22 Debiopharm S.A. Cisplatinum/oxaliplatinum combination
JP3025602B2 (ja) * 1993-05-21 2000-03-27 デビオファーム エス．アー． 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
ES2152412T3 (es) * 1994-08-08 2001-02-01 Debiopharm Sa Preparacion farmaceuticamente estable de oxaliplatino.
DE69531722T2 (de) * 1994-11-11 2004-07-01 Debiopharm S.A. Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
EP0801070B1 (de) 1996-04-10 2003-04-16 Debiopharm S.A. Verfahren zur Herstellung von Platin Verbindungen
JPH09294809A (ja) 1996-05-07 1997-11-18 Terumo Corp 薬液注入器具
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations

Also Published As

Publication number Publication date
AR015524A1 (es) 2001-05-02
UA70316C2 (uk) 2004-10-15
DK0943331T3 (da) 2001-10-15
MXPA00008195A (es) 2004-11-22
PL343021A1 (en) 2001-07-30
GR3036646T3 (en) 2001-12-31
US6306902B1 (en) 2001-10-23
CZ20003089A3 (cs) 2000-12-13
HUP0103707A2 (hu) 2002-02-28
WO1999043355A3 (en) 1999-11-04
JP4430229B2 (ja) 2010-03-10
IL137772A (en) 2006-04-10
CA2261500C (en) 2001-07-17
CN1152718C (zh) 2004-06-09
JP2002504524A (ja) 2002-02-12
EP0943331A2 (de) 1999-09-22
EP0943331B1 (de) 2001-06-27
EP0943331A3 (de) 1999-11-03
NO20004240L (no) 2000-10-18
CZ302196B6 (cs) 2010-12-15
KR20010041182A (ko) 2001-05-15
DE69900162T2 (de) 2002-04-18
ZA991489B (en) 1999-09-30
PL197948B1 (pl) 2008-05-30
RU2207857C2 (ru) 2003-07-10
CA2261500A1 (en) 1999-08-25
ES2161085T3 (es) 2001-11-16
HUP0103707A3 (en) 2004-07-28
HK1036405A1 (en) 2002-01-04
NO329900B1 (no) 2011-01-24
BR9908273A (pt) 2000-10-24
CN1291886A (zh) 2001-04-18
GB9804013D0 (en) 1998-04-22
PT943331E (pt) 2001-12-28
DE69900162D1 (de) 2001-08-02
GT199900019A (es) 2000-08-04
HU224611B1 (hu) 2005-11-28
NO20004240D0 (no) 2000-08-24
AU2632499A (en) 1999-09-15
WO1999043355A2 (en) 1999-09-02
AU757101B2 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
ATE202472T1 (de) Arzneimittel enthaltend oxaliplatin
ATE240732T1 (de) Ziprasidonhaltige arzneimittel
NO20005218L (no) Farmasöytisk aerosolpreparat
DE69938299D1 (de) Lokale abgabe von arzneimitteln
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
DE69513671D1 (de) Arzneimittel
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO20004391D0 (no) Duftforsterkende preparater for kosmetikkprodukter
FI954402L (fi) Uusi farmaseuttinen tuote
ATE285774T1 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
DE59912838D1 (de) Pharmazeutisches faktor vii-präparat
DK1466615T3 (da) Farmaceutisk præparat
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
GB9801538D0 (en) Pharmaceutical product
DE69820861D1 (de) Teilchenförmige arzneimittelträger
ID30032A (id) Formulasi farmasi
GB9802088D0 (en) Pharmaceutical products
ATE237529T1 (de) Tablettenspender
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
DE69906934D1 (de) Arzneizubereitungen
EP1142589A4 (de) Medizinische zusammensetzungen
FI951155A7 (fi) Farmaseuttinen valmiste
DE60008237D1 (de) Lamivudin enthaltende arzneimittel
DE69819203D1 (de) Trinkbares arzneimittel
UA3066S (uk) Упаковка медичного препарату

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification